• Thu, November 20, 2014
  • Fri, November 21, 2014
  • Mon, November 24, 2014
  • Wed, November 19, 2014
  • Tue, November 25, 2014

Evan Seigerman Maintained (BIIB) at Buy with Decreased Target to $400 on, Nov 19th, 2014

Evan Seigerman of Credit Suisse, Maintained "Biogen Inc." (BIIB) at Buy with Decreased Target from $425 to $400 on, Nov 19th, 2014.

Evan has made no other calls on BIIB in the last 4 months.



There are 3 other peers that have a rating on BIIB. Out of the 3 peers that are also analyzing BIIB, 0 agree with Evan's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Evan


  • Brian Skorney of "Baird" Upgraded from Hold to Buy on, Wednesday, October 22nd, 2014
  • Christopher Marai of "Nomura" Maintained at Strong Buy with Increased Target to $424 on, Thursday, July 24th, 2014
  • Andrew Peters of "Deutsche Bank" Maintained at Strong Buy with Increased Target to $430 on, Thursday, July 24th, 2014

Like: 👍

Similar Stocks and Investing Publications